Industry Pipeline - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Industry Pipeline
Interphex Showcase 2010.

Pharmaceutical Technology
Volume 34, Issue 4, pp. 128-135



Dry-material feeder
The PureFeed AP-300 dry-material feeder was designed specifically for pharmaceutical processes. Users can disassemble the device quickly and easily. The machine includes a dual-arm agitation system for versatility in material handling. Its disposable and recyclable EPDM feed hopper complies with US Food and Drug Administration regulations. Schenck AccuRate, Whitewater, WI http://www.accuratefeeders.com/ tel. 888.232.4828



Top-entering agitators
The PharMix Series 3000 and 4000 top-entering agitators are specifically designed for demanding pharmaceutical and biotechnology mixing applications. The units' robust shaft designs run in free air for cleaning in place and eliminate the need for stabilizing rings. Each agitator comes with a complete prevalidation documentation package. DCI, St. Cloud, MN http://www.dciinc.com/ tel. 320.252.8200



Double rotary tablet press
Fette's 3200i double rotary tablet press is suitable for large to medium-sized nutritional batches. The press's segment technology helps increase productivity for single-layer and double-layer tablets.The unit's exchangeable segment turrets simplify cleaning, increase yield, and speed format change. The device also enables automatic process monitoring. Fette America, Rockaway, NJ http://www.fetteamerica.com/ tel. 973.586.8722



Sterile connector
The 1-in. Pure-Fit SC sterile connector is designed with the same features as Saint-Gobain's other connectors, but in a large, versatile size for great flow volume. The silicone valve design allows easy assembly, and the patented Pure-Fit SIB technology is designed to ensure a smooth inner bore. Saint-Gobain Performance Plastics, Clearwater, FL http://www.biopharm.saint-gobain.com/ tel. 800.541.6880


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
27%
Breakthrough designations
9%
Protecting the supply chain
41%
Expedited reviews of drug submissions
9%
More stakeholder involvement
14%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here